Adastra Holdings Ltd
CNSX:XTRX
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Adastra Holdings Ltd
Adastra Holdings Ltd. engages in the provision of large-scale cannabis and hemp extraction technologies and provide turn-key processing solutions to help licensed standard and micro-cultivators maximize the value of every harvest. The company is headquartered in Langley, British Columbia. The company went IPO on 2020-01-06. The firm is a manufacturer and supplier of ethnobotanical and cannabis science products designed for the adult use and medical markets and therapeutic applications. The company is focused on its line of Phyto Extractions branded cannabis concentrate products. The firm also operates Adastra Labs, which is focused on extraction, distillation, and manufacturing of cannabis derived products. The company is a cultivator, tester, extractor, and seller of controlled substances, including Psilocybin, Psilocin, N-Dimethyltryptamine (DMT) and various others. The firm operates a multidisciplinary center for medical cannabis and psychedelic therapies, working alongside doctors and healthcare professionals through 1225140 B.C. Ltd.
Adastra Holdings Ltd. engages in the provision of large-scale cannabis and hemp extraction technologies and provide turn-key processing solutions to help licensed standard and micro-cultivators maximize the value of every harvest. The company is headquartered in Langley, British Columbia. The company went IPO on 2020-01-06. The firm is a manufacturer and supplier of ethnobotanical and cannabis science products designed for the adult use and medical markets and therapeutic applications. The company is focused on its line of Phyto Extractions branded cannabis concentrate products. The firm also operates Adastra Labs, which is focused on extraction, distillation, and manufacturing of cannabis derived products. The company is a cultivator, tester, extractor, and seller of controlled substances, including Psilocybin, Psilocin, N-Dimethyltryptamine (DMT) and various others. The firm operates a multidisciplinary center for medical cannabis and psychedelic therapies, working alongside doctors and healthcare professionals through 1225140 B.C. Ltd.
